These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25612785)

  • 61. Use of sildenafil for pulmonary hypertension in neonates.
    Márquez-González H; Ríos DI; Jean Tron MG; Barajas-Nava LA
    Bol Med Hosp Infant Mex; 2020; 77(4):202-206. PubMed ID: 32713951
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systematic review and cost-effectiveness of bosentan and sildenafil as therapeutic drugs for pediatric pulmonary arterial hypertension.
    Chen T; Chen J; Chen C; Zheng H; Chen Y; Liu M; Zheng B
    Pediatr Pulmonol; 2021 Jul; 56(7):2250-2258. PubMed ID: 33856119
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
    J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia successfully treated with sildenafil.
    Miyake R; Fujino T; Abe K; Hosokawa K; Ohtani K; Morisaki H; Yamada O; Higo T; Ide T
    Int J Cardiol; 2016 Jul; 214():275-6. PubMed ID: 27077548
    [No Abstract]   [Full Text] [Related]  

  • 66. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
    Kothari SS; Duggal B
    Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacodynamic considerations in the treatment of pulmonary hypertension in infants: challenges and future perspectives.
    Kraemer U; Cochius-den Otter S; Snoek KG; Tibboel D
    Expert Opin Drug Metab Toxicol; 2016; 12(1):1-19. PubMed ID: 26558492
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Arterial hypotension and prerenal failure in an extremely preterm infant associated with oral sildenafil.
    Balasubramanian H; Strunk T; Kohan R
    J Perinatol; 2015 Jun; 35(6):458-9. PubMed ID: 26012476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia.
    Lilyasari O; Subekti Y; Atika N; Dinarti LK; Putri S; Opitasari C; Anggraini AB; Bussabawalai T; Teerawattananon Y
    BMC Health Serv Res; 2019 Aug; 19(1):573. PubMed ID: 31412857
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
    Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
    Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'.
    Wong GR; Lau DH; Baillie TJ; Middeldorp ME; Steele PM; Sanders P
    Int J Cardiol; 2015 Feb; 181():55-6. PubMed ID: 25482279
    [No Abstract]   [Full Text] [Related]  

  • 75. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.
    Sable CA; Ivy DD; Beekman RH; Clayton-Jeter HD; Jenkins KJ; Mahle WT; Morrow WR; Murphy MD; Nelson RM; Rosenthal GL; Stockbridge N; Wessel DL
    Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28663437
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension.
    Karatza AA; Bush A; Magee AG
    Int J Cardiol; 2005 Apr; 100(2):267-73. PubMed ID: 15823634
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of enteral sildenafil in hemodynamically unstable children.
    Bednarz AM; Israel EN; Beckman EJ; Johansen M; Thomas CA
    Cardiol Young; 2019 May; 29(5):589-593. PubMed ID: 31046848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.